Molecule intelOpportunity: ModerateEssentialCrowded market

Loratadine

359 brands · 205 companies · product forms

ATC: R06AX13 39 DRAP alerts

Opportunity snapshot

Launch attractiveness
49
Market saturation
100
Price room
100
Regulatory risk
90
359
brands
205
companies
Rs 129.26
median price
299
price points
587.14x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 2%

Price room

Across observed sources and strengths
CheapestRs 18.53
MedianRs 129.26
Most expensiveRs 10,879.72
Spread587.14×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 587.14x across 299 trusted points (Rs 18.53-10879.72). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Loratadine — each links to its own medicine page.

Regulatory alerts

Recall exposureSafety exposurelatest 2026-04-14
RECALL ALERT – BATCHES OF ‘TABLET FAMILA 28F’ DECLARED SUBSTANDARD BY CENTRAL DRUGS LABORA
02. Recall Alert (Class-II) – Drug Products tested by DTL Punjab
23. Recall Alert – Class II – Drug Products – Provincial reports
Recall Alert: Recall of Nabaxo 10mg Film Coated Tablet Manufactured By M/s. Wenovo Pharmac
Recall Alert – Adulterated Tablet Virtec 10 mg (Batch # FK-24-007)
RAPID ALERT – SPURIOUS / FALSIFIED (TABLET FEMARA 2.5 mg)

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

205 canonical companies and 359 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 587.14x across 299 trusted points (Rs 18.53-10879.72). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

39 DRAP alert(s), latest 2026-04-14 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.